SMM
FBT icon

Stadion Money Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Stadion Money Management’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-42,665
Closed -$2.77M – 106
2013
Q3 		$2.77M Buy
42,665
+20,777
+95% +$1.31M 0.06% 52
2013
Q2 		$1.27M Buy
+21,888
New +$1.25M 0.07% 78

Other funds holding FBT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Stadion Money Management's FBT Position: Q4 2013 in Review

Stadion Money Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2013, closing a stake of 42,665 shares — an estimated $2.77M sold.

Stadion Money Management first reported a position in FBT in Q2 2013 and held it in 2 quarters. The position peaked at $2.77M in Q3 2013. 79 funds tracked by Wall St. Rank hold FBT as of Q4 2013.

  • Stadion Money Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2013 after selling out during the quarter.
  • Stadion Money Management sold 42,665 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2013, an estimated $2.77M.
  • Stadion Money Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and held it in 2 quarters.
  • Stadion Money Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $2.77M in Q3 2013.
  • 79 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2013.

Based on Stadion Money Management's 13F filing for Q4 2013, filed 14 Feb 2014.